INDEC Systems will introduce its updated FluorVivo imaging chamber in Booth 1002 at the upcoming annual meeting of the American Association for Cancer Research (AACR). Since the introduction of the original FluorVivo system two years ago, INDEC’s FluorVivo family of products has redefined the marketplace for in vivo fluorescence imaging, setting new standards for cost-effective imaging, bringing this technology to labs and core facilities uninterested in ‘big box’ imaging systems. The new imaging chamber is part of INDEC’s continuing development of the FluorVivo system, and provides FluorVivo’s macroscopic imaging systems greater flexibility and makes them even easier to use and maintain. INDEC will display the new chamber at the meeting in both its Model 100 and Model 300 macro-imaging systems.

INDEC BioSystems announces the introduction of its newest product for in vivo fluorescence imaging – FluorVivo Mag™. Designed to fill a void in the existing marketplace, FluorVivo Mag™ brings digital imaging to in vivo applications with widely disparate spatial scales, ranging from the macroscopic to the microscopic. This wide range of magnifications makes it possible for users to move between ‘whole animal’ and cellular imaging, and makes FluorVivo Mag™ an ideal instrument for in vivo studies of the interaction between single cells and their environment. FluorVivo Mag™ can also be combined with either of INDEC’s other FluorVivo imaging systems – Model 100 or Model 300 – to form an integrated in vivo imaging workstation with imaging capabilities ranging from the subcellular to multiple animals. [MORE]

Following up on last year’s debut of its FluorVivo™ imaging system, INDEC Systems is pleased to announce the introduction of the FluorVivo Model 300 system at this year’s annual meeting of the American Association for Cancer Research (AACR). The original FluorVivo instrument, now known as the FluorVivo Model 100, provides excitation light in one band of wavelengths and is typically configured for imaging of the green fluorescent proteins, GFP and eGFP.  The new Model 300 instrument is much more versatile, and provides excitation light in up to 3 different wavelength bands, each with high intensity, long-lifetime LEDs.  By choosing 3 bands from the many available, spanning nearly the visible and near infra-red (IR) spectrum, users will find it easy to configure a Model 300 system to meet their exact requirements. [MORE]

INDEC Systems, Inc. (INDEC, President: Mr. Kal Hubler, headquarters Santa Clara, California, U.S.A.) has formed a strategic partnership with AntiCancer Inc. (CEO: Dr. Robert M. Hoffman, headquarters: San Diego, California, U.S.A.). Starting in July 18, 2006, INDEC Biosystems introduce new fluorescence imaging systems, especially suited to the unique opportunities presented by AntiCancer’s proprietary fluorescent-protein-based small-animal technologies, including their mouse models of cancer, MetaMouse® and AngioMouse®.

Annual Meeting
Washington, DC
April 17 to 21, 2010

Annual Meeting
Chicago, IL
May 3 to 6, 2010

Annual Meeting
Chicago, IL
June 4 to 8, 2010

Annual Meeting
San Francisco, CA
June 16 to 19, 2010

Annual Meeting
Kyoto, Japan
Sept. 8 to 11, 2010

Annual Meeting
San Diego, CA
Nov. 13 to 17, 2010